INSM
Insmed IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.92B
P/E Ratio
—
EPS
$-5.76
Beta
0.77
52W High
$212.75
52W Low
$90.39
50-Day MA
$128.54
200-Day MA
$154.93
Dividend Yield
—
Profit Margin
-144.40%
Forward P/E
16.37
PEG Ratio
1.09
About Insmed Inc
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | $819.56M |
| Gross Profit (TTM) | $670.48M |
| EBITDA | $-949.04M |
| Operating Margin | -65.50% |
| Return on Equity | -294.50% |
| Return on Assets | -31.10% |
| Revenue/Share (TTM) | $3.95 |
| Book Value | $3.25 |
| Price-to-Book | 28.97 |
| Price-to-Sales (TTM) | 26.19 |
| EV/Revenue | 24.13 |
| EV/EBITDA | -6.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 229.60% |
| Shares Outstanding | $216.75M |
| Float | $198.29M |
| % Insiders | 0.52% |
| % Institutions | 105.65% |
Historical Volatility
HV 10-Day
72.49%
HV 20-Day
57.44%
HV 30-Day
98.28%
HV 60-Day
77.89%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($199.00 target)
5
Strong Buy17
BuyMore HEALTHCARE Stocks
Data last updated: 6/11/2026